Alzheimer's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 50 or older who are being seen as outpatients (not staying in hospital), of any gender.
- People who have been diagnosed with Mild Cognitive Impairment (MCI) according to Mayo Clinic Criteria — a condition involving mild memory or thinking changes.
- People who have access to the internet through a computer.
- People who can speak and read English, or who have a family member who can speak and read English and is willing to help with translation.
- People whose vision and hearing are good enough to take part in the study activities.
Who may not be able to join:
- People who score below 19 on a standard memory and thinking test (called the Mini Mental State Exam), or who have been diagnosed by a doctor with moderate or severe dementia.
- People where the trial investigator believes taking part would not be in the person's best interest (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Yonas E Geda, M.D, MSc, Barrow Neurological Institute, Alzheimer's Disease and Cognitive Disorders Division
Phone: 833-233-3073
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Working Memory as measured by the WAIS-IV Digit Span Forward/Backward; Working Memory as measured by the TMT-B; Working Memory as measured by Category Fluency Test
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.